ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Jun 04, 2020 22:00 JST
Source:
LABMED
Singapore's LABMED shipped over 20 million masks to meet global demand
Rising Singapore medical equipment company has been supplying much needed masks, PPEs to Covid-19 hotspots worldwide
SINGAPORE, Jun 04, 2020 - (JCN Newswire) - Singapore based LABMED is playing a crucial role in supplying medical masks and medical personal protective equipment (PPE) globally, to countries such as India, Malaysia, Germany and the US.
LABMED's Regional Managing Director, Wilson, and Managing Director, Jason.
To date, LABMED has shipped over 20 million masks globally. With the increase in demand for PPEs and other medical supplies during the current Covid-19 crisis, LABMED's Regional Managing Director, Wilson, elaborates how they are contributing in the fight against this global pandemic, "Our manufacturing plant in China has 480 employees working round the clock to produce medical PPEs. These are all quality products that have received worldwide certifications."
"Our company also recently introduced into Singapore our latest product - the VTM (Virus Transport Medium) kits for the transport and containment of Covid-19 swab test results," adds Jason, who is the Managing Director.
Having collaborated with many well-known organizations to provide R&D and procurement services for specialized medical supplies, LABMED is making its global presence felt in the sales of pharmaceutical devices.
In a short span of four months, from 1 Feb 2020 to 1 June 2020, the company's revenue increased exponentially to hit more than S$35 million.
LABMED had been predominantly supplying their products to the US, Germany and the UAE, however, the developing Covid-19 situation has seen the company enter new markets with the urgent call to supply much needed PPEs from Asia to Covid-19 'hot-spots' in Europe and North America.
About LABMED
LABMED, a subsidiary of Kin Seng Hong Pte Ltd that was established since 1977, is a brand created by Wilson and Jason (known as Labelmed Pte Ltd) that specializes in the manufacture of disposable civil mask, medical mask, surgical mask, KN95-FFP2 mask and other medical instruments. Strategically headquartered in Singapore with access to a wide distribution network both locally and globally. The company has a strong connection in exporting products all over the world, with special focus on the US, France, Germany and United Kingdom.
The company has collaborated with many local well-known medical device companies, MNCs as well as government entities to provide new and existing customers with procurement services for medical supplies such as medical masks, protective suit, rubber gloves, goggles, thermometer, disinfectant, hand lotion, mask production equipment as well as nasal swab test kit for Covid-19.
LABMED has a large inventory of medical masks, they are able to handle fast delivery, and ensure direct-factory price supply. Website:
https://thelabmed.com/
For more information, please contact:
Rebecca
Marketing Director
rebecca@labelmed.com.sg
Source: LABMED
Sectors: Transport & Logistics, Healthcare & Pharm
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 09:22 JST
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
Honda Unveils Next-generation EV Series for China
Apr 17, 2024 12:15 JST
Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST
Mitsubishi Corporation Announces Participation in a DAC Project in Louisiana, USA
Apr 16, 2024 14:36 JST
New circuit challenge for TOYOTA GAZOO Racing
Apr 15, 2024 17:21 JST
TOYOTA GAZOO Racing back on asphalt for Croatian challenge
Apr 12, 2024 19:36 JST
Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
Apr 12, 2024 14:39 JST
MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
Apr 11, 2024 18:08 JST
Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
Apr 11, 2024 17:50 JST
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
Apr 11, 2024 15:10 JST
Mitsubishi Corporation Announces Completion of Capital Raise by Nexamp
Apr 11, 2024 13:07 JST
Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
Apr 10, 2024 16:55 JST
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
Apr 10, 2024 13:36 JST
More Latest Release >>